Martha Shadan - 12 Dec 2023 Form 4 Insider Report for LEMAITRE VASCULAR INC (LMAT)

Role
Director
Signature
/s/ David C. Hissong
Issuer symbol
LMAT
Transactions as of
12 Dec 2023
Net transactions value
$0
Form type
4
Filing time
13 Dec 2023, 16:58:59 UTC
Previous filing
12 Dec 2023
Next filing
04 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LMAT Common Stock Options Exercise $0 +1 +0.09% $0.000000 1,106 12 Dec 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LMAT Dividend Equivalent Rights Options Exercise $0 -1 -17% $0.000000 5 12 Dec 2023 Common Stock 1 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis.
F2 These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/12/2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.